Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis

Abstract Studies have shown that the prevalence of RAS and BRAF mutations may differ by tumor sidedness among metastatic colorectal cancer (mCRC) patients. Both mutation status and tumor sidedness may impact survival and disease progression and RAS mutation status has been shown to predict response...

Full description

Bibliographic Details
Main Authors: Lauren C. Bylsma, Christina Gillezeau, Tamer A. Garawin, Michael A. Kelsh, Jon P. Fryzek, Laura Sangaré, Kimberly A. Lowe
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2747